.Merck trumps revenues desires, brings up purchases expectation on solid requirement for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Beats Profit Forecasts as Keytruda Sales Rise BloombergMerck Sell: Pharma Giant Posts Powerful Results, However Overview Falls Short Capitalist's Company DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck beats revenue and also purchases assumptions among Keytruda strength, however provides blended full-year outlook MarketWatch.